Evolus (EOLS) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free EOLS Stock Alerts $11.53 -0.03 (-0.26%) (As of 05:21 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEvolus reports 6-month efficacy of Jeuveau in glabellar lines studyinvesting.com - April 18 at 11:14 PMShort Interest in Evolus, Inc. (NASDAQ:EOLS) Declines By 6.6%americanbankingnews.com - April 18 at 5:10 AMEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®finance.yahoo.com - April 17 at 8:32 PMEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®businesswire.com - April 17 at 4:05 PMEvolus, Inc. (NASDAQ:EOLS) Sees Significant Decrease in Short Interestmarketbeat.com - April 16 at 12:23 PMVanguard Group Inc. Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)marketbeat.com - April 13 at 4:31 AMEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 12 at 4:05 PMEvolus (NASDAQ:EOLS) Given Buy Rating at Needham & Company LLCamericanbankingnews.com - April 11 at 5:14 AMNeedham & Company LLC Reaffirms "Buy" Rating for Evolus (NASDAQ:EOLS)marketbeat.com - April 10 at 8:17 AMEvolus, Inc. (NASDAQ:EOLS) is Stonepine Capital Management LLC's Largest Positionmarketbeat.com - April 9 at 9:43 PMEvolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the companyfinance.yahoo.com - April 6 at 2:55 PMEvolus (NASDAQ:EOLS) Shares Gap Down to $13.76marketbeat.com - April 3 at 1:35 PMInsider Selling: Evolus, Inc. (NASDAQ:EOLS) Insider Sells 6,236 Shares of Stockinsidertrades.com - March 30 at 7:38 AMEvolus, Inc. (NASDAQ:EOLS) Insider David Moatazedi Sells 6,236 Sharesmarketbeat.com - March 29 at 9:16 PMEvolus to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - March 26 at 10:00 AMEvolus, Inc. (NASDAQ:EOLS) CFO Sells $78,954.24 in Stockinsidertrades.com - March 24 at 5:58 AMInsider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 5,672 Shares of Stockmarketbeat.com - March 21 at 7:57 PMEvolus (NASDAQ:EOLS): An Attractive Aesthetics Stock for Growth Investorsmsn.com - March 21 at 8:11 AMEvolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028seekingalpha.com - March 20 at 5:09 PMWalleye Capital LLC Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)marketbeat.com - March 17 at 4:20 AMAnalysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO) and Evolus (EOLS)markets.businessinsider.com - March 14 at 10:40 AMEvolus Inc.wsj.com - March 12 at 8:31 PMLatest News for Evolus Stock (NASDAQ:EOLS)benzinga.com - March 12 at 8:31 PMEvolus Poised for Growth: Buy Rating Affirmed with $25 Price Target Amid Profitability Forecast and Competitive Market Positioningmarkets.businessinsider.com - March 11 at 6:48 PMEvolus Reports Pricing Of $50 Mln Underwritten Offering Of Common Stockmarkets.businessinsider.com - March 11 at 8:47 AMEvolus (EOLS) Receives a Buy from Barclaysmarkets.businessinsider.com - March 11 at 8:47 AMEvolus prices stock offering to raise about $50Mmsn.com - March 11 at 8:47 AMSchroder Investment Management Group Purchases 115,647 Shares of Evolus, Inc. (NASDAQ:EOLS)marketbeat.com - March 11 at 7:22 AMEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stockbusinesswire.com - March 11 at 7:00 AMAnalyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Reportfinance.yahoo.com - March 10 at 2:31 PMSchonfeld Strategic Advisors LLC Purchases Shares of 131,342 Evolus, Inc. (NASDAQ:EOLS)marketbeat.com - March 10 at 5:45 AMEvolus Full Year 2023 Earnings: In Line With Expectationsfinance.yahoo.com - March 9 at 12:15 PMEvolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcriptmsn.com - March 8 at 5:50 PMEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 8 at 4:05 PMEvolus Poised for Growth: Surpassing Q4 Expectations and Accelerating Profitabilitymarkets.businessinsider.com - March 8 at 12:44 PMEvolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024finance.yahoo.com - March 8 at 2:34 AMEOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023investorplace.com - March 7 at 11:06 PMEvolus, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 7 at 10:41 PMEvolus GAAP EPS of -$0.21 in-line, revenue of $61M in-linemsn.com - March 7 at 9:29 PMRecap: Evolus Q4 Earningsbenzinga.com - March 7 at 9:29 PMEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidancebusinesswire.com - March 7 at 4:05 PMEvolus Q4 2023 Earnings Previewmsn.com - March 6 at 10:19 PMEvolus earnings: here's what to expectmarkets.businessinsider.com - March 6 at 5:19 PMEarnings Outlook For Evolusbenzinga.com - March 6 at 5:19 PMEvolus (NASDAQ:EOLS) Reaches New 12-Month High at $15.20marketbeat.com - March 4 at 10:52 AMEvolus reports dermal filler edges out Restylane-L in studyinvesting.com - March 3 at 12:18 AMEvolus (NASDAQ:EOLS) Given "Buy" Rating at HC Wainwrightmarketbeat.com - March 1 at 2:51 PMEvolus Announces Results from European Head-to-Head Filler Trialfinance.yahoo.com - March 1 at 10:06 AMEvolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferencesfinance.yahoo.com - February 27 at 1:06 PMEvolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferencesbusinesswire.com - February 27 at 8:30 AM Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. EOLS Media Mentions By Week EOLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EOLS News Sentiment▼0.790.52▲Average Medical News Sentiment EOLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EOLS Articles This Week▼82▲EOLS Articles Average Week Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Varex Imaging News Today Mind Medicine (MindMed) News Today Praxis Precision Medicines News Today Silk Road Medical News Today PureTech Health News Today Dianthus Therapeutics News Today Treace Medical Concepts News Today Savara News Today enGene News Today OrthoPediatrics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EOLS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.